Matthew Kroh, MD

Appointed
2007

Education & Fellowships

Fellowship - Cleveland Clinic
Surgical Endoscopy
Cleveland, OH USA
2008

Residency - Cleveland Clinic
General Surgery
Cleveland, OH USA
2007

Medical Education - The Mount Sinai School of Medicine
M.D.
New York, NY USA
2002

Graduate School - Boston University
Boston, MA USA
1998

Undergraduate - Boston College
Chestnut Hill, MA USA
1996

Professional Highlights

• Vice Chair, Innovation and Technology
  
• Professor of Surgery, Cleveland Clinic Lerner College of Medicine
• Section Head, Surgical Endoscopy and Foregut Surgery

Certifications

• Surgery - General Surgery
• Focused Practice in Metabolic Bariatric Surgery

Specialty Interests

Advanced laparoscopic surgery, complex endoscopy, achalasia operations, anti-reflux, and bariatric surgery. Surgery of the gastrointestinal tract, bariatric medicine, bariatric operations, bariatric surgery, endoluminal surgery, endoscopy in the obese patient, Interventional endoscopy, gastric cancer, gastrointestinal surgery, gastric surgery with focus on reflux disease, hiatal hernia, laparoscopic solid organ surgery including splenectomy and adrenalectomy, Medical education, Resident and Fellow Education, Robotic Surgery, Single incision laparoscopic surgery, weight loss surgery, Weight Management, Robotic surgery, Median arcuate ligament syndrome, Gastric pacemaker

Awards & Honors

• Outstanding Teacher of the Year, Department of General Surgery
• Innovator Awards

Memberships

• Society of American Gastrointestinal Endoscopic Surgeons
• American Society for Metabolic and Bariatric Surgery
• American College of Surgeons
• American Society of Gastrointestinal Endoscopists
• Association of Surgical Educators
• Central Surgical Association
• American Surgical Association

See publications for Matthew Kroh, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/6/2024, Dr. Kroh has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Kroh receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Medtronic plc

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.